Search research articles
Contact Us
Filters
Showing results (311-320 of 530) with videos related to
Page
of 53
Sort By:
Genetics
|
February 1, 1995
Structure and evolution of genes encoding polyubiquitin and ubiquitin-like proteins in Arabidopsis thaliana ecotype Columbia
J Callis, T Carpenter, C W Sun, et al.
Actas Luso-Espanolas De Neurologia, Psiquiatria Y Ciencias Afines
|
August 26, 1998
[The deficit syndrome: a domain of schizophrenia]
C Arango, B Kirkpatrick, R W Buchanan, et al.
Schizophrenia Bulletin
|
June 15, 2005
At issue: A model for academic/industry collaboration
William T Carpenter, James I Koenig, Graeme Bilbe, et al.
The Journal of Nervous and Mental Disease
|
August 1, 1994
Depressive symptoms and the deficit syndrome of schizophrenia
B Kirkpatrick, R W Buchanan, A Breier, et al.
Biological Psychiatry
|
February 25, 1998
Hypothesis testing: is clozapine's superior efficacy dependent on moderate D2 receptor occupancy?
W T Carpenter, J M Zito, J Vitrai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Decreased dihydropyrimidine dehydrogenase activity in a population of patients with breast cancer: implication for 5-fluorouracil-based chemotherapy
Z Lu, R Zhang, J T Carpenter, et al.
Psychiatric Services (Washington, D.C.)
|
October 3, 2000
Clozapine treatment of outpatients with schizophrenia: outcome and long-term response patterns. 1993
A Breier, R W Buchanan, D Irish, et al.
Schizophrenia Bulletin
|
February 7, 2001
Risk factors for the deficit syndrome of schizophrenia
B Kirkpatrick, D Castle, R M Murray, et al.
Hospital & Community Psychiatry
|
December 1, 1993
Clozapine treatment of outpatients with schizophrenia: outcome and long-term response patterns
A Breier, R W Buchanan, D Irish, et al.
Cancer Treatment Reports
|
October 1, 1986
Phase II evaluation of fludarabine in patients with metastatic breast cancer: a Southeastern Cancer Study Group trial
J T Carpenter, C L Vogel, G Wang, et al.
Page
of 53
Search research articles
Search
Showing results (311-320 of 530) with videos related to
Sort By:
Page
of 53
Genetics
|
February 1, 1995
Structure and evolution of genes encoding polyubiquitin and ubiquitin-like proteins in Arabidopsis thaliana ecotype Columbia
J Callis, T Carpenter, C W Sun, et al.
Actas Luso-Espanolas De Neurologia, Psiquiatria Y Ciencias Afines
|
August 26, 1998
[The deficit syndrome: a domain of schizophrenia]
C Arango, B Kirkpatrick, R W Buchanan, et al.
Schizophrenia Bulletin
|
June 15, 2005
At issue: A model for academic/industry collaboration
William T Carpenter, James I Koenig, Graeme Bilbe, et al.
The Journal of Nervous and Mental Disease
|
August 1, 1994
Depressive symptoms and the deficit syndrome of schizophrenia
B Kirkpatrick, R W Buchanan, A Breier, et al.
Biological Psychiatry
|
February 25, 1998
Hypothesis testing: is clozapine's superior efficacy dependent on moderate D2 receptor occupancy?
W T Carpenter, J M Zito, J Vitrai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Decreased dihydropyrimidine dehydrogenase activity in a population of patients with breast cancer: implication for 5-fluorouracil-based chemotherapy
Z Lu, R Zhang, J T Carpenter, et al.
Psychiatric Services (Washington, D.C.)
|
October 3, 2000
Clozapine treatment of outpatients with schizophrenia: outcome and long-term response patterns. 1993
A Breier, R W Buchanan, D Irish, et al.
Schizophrenia Bulletin
|
February 7, 2001
Risk factors for the deficit syndrome of schizophrenia
B Kirkpatrick, D Castle, R M Murray, et al.
Hospital & Community Psychiatry
|
December 1, 1993
Clozapine treatment of outpatients with schizophrenia: outcome and long-term response patterns
A Breier, R W Buchanan, D Irish, et al.
Cancer Treatment Reports
|
October 1, 1986
Phase II evaluation of fludarabine in patients with metastatic breast cancer: a Southeastern Cancer Study Group trial
J T Carpenter, C L Vogel, G Wang, et al.
Page
of 53